Cargando…
A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493498/ http://dx.doi.org/10.1186/2045-7022-5-S4-P34 |
| _version_ | 1782379927942725632 |
|---|---|
| author | Hellings, Peter Bachert, Claus Mösges, Ralph Scadding, Glenis Munzel, Ullrich Fokkens, Wytske |
| author_facet | Hellings, Peter Bachert, Claus Mösges, Ralph Scadding, Glenis Munzel, Ullrich Fokkens, Wytske |
| author_sort | Hellings, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4493498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44934982015-07-15 A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies Hellings, Peter Bachert, Claus Mösges, Ralph Scadding, Glenis Munzel, Ullrich Fokkens, Wytske Clin Transl Allergy Poster Presentation BioMed Central 2015-06-26 /pmc/articles/PMC4493498/ http://dx.doi.org/10.1186/2045-7022-5-S4-P34 Text en Copyright © 2015 Hellings et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Hellings, Peter Bachert, Claus Mösges, Ralph Scadding, Glenis Munzel, Ullrich Fokkens, Wytske A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| title | A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| title_full | A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| title_fullStr | A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| title_full_unstemmed | A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| title_short | A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| title_sort | new allergic rhinitis therapy (mp29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493498/ http://dx.doi.org/10.1186/2045-7022-5-S4-P34 |
| work_keys_str_mv | AT hellingspeter anewallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT bachertclaus anewallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT mosgesralph anewallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT scaddingglenis anewallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT munzelullrich anewallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT fokkenswytske anewallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT hellingspeter newallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT bachertclaus newallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT mosgesralph newallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT scaddingglenis newallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT munzelullrich newallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies AT fokkenswytske newallergicrhinitistherapymp2902providesnasalandocularsymptomreliefdaysfasterthancurrentfirstlinemonotherapies |